ApoA-I Monoclonal Antibody

This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The encoded preproprotein is proteolytically processed to generate the mature protein, which promotes cholesterol efflux from tissues to the liver for excretion, and is a cofactor for lecithin cholesterolacyltransferase (LCAT), an enzyme responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein.

Introducing the APOA-I Monoclonal Antibody, a highly effective and reliable product designed to target and neutralize Apolipoprotein A-I (APOA-I) in various applications. This monoclonal antibody is produced using state-of-the-art technology and is characterized by its high specificity and affinity towards APOA-I.

The APOA-I Monoclonal Antibody is an essential tool for researchers and scientists working in the fields of cardiovascular disease, lipid metabolism, and atherosclerosis. It can be used in a variety of applications, including Western blotting, ELISA, immunohistochemistry, and flow cytometry.

This product is manufactured to the highest standards of quality and purity, ensuring consistent and reproducible results. It is supplied in a convenient and easy-to-use format, making it ideal for both academic and industrial research applications.

In summary, the APOA-I Monoclonal Antibody is a valuable addition to any laboratory or research facility, providing a reliable and effective tool for the study of APOA-I and its role in various physiological and pathological processes.